Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2018-05-09 AGM Information
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Document availability communications / Preparatory documents for the general meeting
AGM Information Classification · 98% confidence The document explicitly announces the 'Combined Shareholders' Meeting of 30 May 2018' and details the availability and consultation of preparatory documents for this meeting. This directly relates to the governance and shareholder meeting process. Since the document is an announcement about the meeting and the availability of materials, and not the voting results (DVA) or the full proxy statement (PSI), the most appropriate classification is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM). The length (3435 chars) is short enough that it could potentially be an RPA, but the content is specifically about the AGM logistics and document availability, making AGM-R a better fit than a generic RPA.
2018-05-09 English
Communiqués de mise à disposition de documents / Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document is titled 'Assemblée Générale Mixte du 30 mai 2018' (Mixed General Meeting of May 30, 2018) and discusses the modalities for making preparatory documents available and consulting them for the upcoming AGM. It explicitly mentions the 'avis de convocation' (notice of meeting) and the 'Brochure de convocation' (Notice Brochure) which includes the agenda and draft resolutions. This content is directly related to the materials prepared for and distributed before an Annual General Meeting. Therefore, the most appropriate classification is AGM Information (AGM-R). The document length (3644 chars) is short, but it is the actual announcement/information regarding the AGM logistics, not just a notice that the AGM materials are available (which would be RPA/RNS).
2018-05-09 French
Quarterly financial report / First quarter financial report
Earnings Release Classification · 98% confidence The document is titled with a clear reference to 'strong first quarter 2018 sales growth' and contains detailed financial tables comparing Q1 2018 sales to Q1 2017 sales, including revenue figures by therapeutic area and geography. This structure is characteristic of an Earnings Release (ER), which provides initial highlights of periodical financial results. It is not a comprehensive Annual Report (10-K) or a full Interim/Quarterly Report (IR) as it focuses on sales highlights and confirms guidance, rather than presenting full audited statements or management's detailed discussion and analysis (MDA). The presence of a conference call announcement further supports this being an earnings-related release. Q1 2018
2018-04-26 English
Information financière trimestrielle / Information financière du premier trimestre
Interim / Quarterly Report Classification · 100% confidence The document is a detailed financial report for the first quarter of 2018 (Q1 2018) for Ipsen. It contains comprehensive financial data, including consolidated revenue, sales breakdowns by therapeutic area, product-specific performance, and geographic distribution. It is not a short announcement or a certification, but a substantive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2018-04-26 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Information mensuelle relative au nombre total des droits de vote et d'actions composant le capital social' (Monthly information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the AMF General Regulation (French financial market authority) and provides a table detailing the total number of shares and voting rights as of March 31, 2018. This type of mandatory periodic disclosure regarding the total share capital and voting rights structure is a specific regulatory filing, but it does not map perfectly to the provided definitions (like 10-K, ER, or IR). However, it relates closely to changes in capital structure or major shareholdings. Since it is a mandatory regulatory disclosure that doesn't fit the specific categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification), the most appropriate general regulatory category is 'Regulatory Filings' (RNS), as it is a standard, periodic regulatory update not covered by the more specific options. Given the content focuses purely on the total number of shares and voting rights, it is a specific regulatory disclosure.
2018-04-12 French
Information relating to the total number of voting rights and shares making up the capital
Declaration of Voting Results & Voting Rights Announcements Classification · 89% confidence The document is titled "Monthly information regarding the total number of voting rights and total number of shares of the Company" and references Article 223-16 of the AMF General Regulations. It provides a table detailing the total number of shares and voting rights as of a specific date (March 31, 2018). This content relates to the official disclosure of share capital structure and voting power, which is a specific regulatory disclosure. It does not fit the definitions for Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a general Regulatory Filing (RNS). It is most closely related to disclosures concerning capital structure or shareholder information, but none of the specific codes (like SHA for share issue or DVA for voting results) perfectly match a routine monthly voting rights disclosure. However, given the options, this type of routine disclosure about the number of shares and voting rights is often categorized under general capital/share information. Since there is no specific code for 'Monthly Voting Rights Disclosure', and it is a formal regulatory disclosure, I must choose the best fit. It is not a dividend announcement (DIV), director dealing (DIRS), or major shareholding notification (MRQ). Since it deals with the total number of shares and voting rights, it touches upon capital structure, but it is not a financing event (CAP) or a share repurchase (POS). Given the lack of a perfect fit, and recognizing this as a mandatory regulatory disclosure about the share base, I will re-evaluate the definitions. The closest related concepts are DVA (Declaration of Voting Results) or SHA (Share Issue/Capital Change). Since this is a routine monthly update on the *total* rights, and not the result of a specific vote or a new issuance, it is a unique regulatory filing. In many databases, such routine disclosures fall under a general regulatory category. Given the provided list, and noting that it is a formal regulatory disclosure that doesn't fit the specific financial reports or corporate actions, RNS (Regulatory Filings - general fallback) is the most appropriate category for a mandatory, non-standard disclosure.
2018-04-12 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.